Chemotherapy: Open Access
Open Access
ISSN: 2167-7700
ISSN: 2167-7700
Monica Di Battista
Italy
Commentary
First-Line Platinum-Based Chemotherapy Re-challenge in Sensitive Small Cell Lung Cancer (SCLC): A Standard Treatment?
Author(s): Giovenzio Genestreti, Monica Di Battista, Giovanna Cavallo and Alba Brandes
Giovenzio Genestreti, Monica Di Battista, Giovanna Cavallo and Alba Brandes
Small cell lung cancer (SCLC) has typically high sensitivity to chemotherapy and radiotherapy, although greater part of patients with limited disease (LD) and all patients with extended disease (ED) will develop disease relapse or progression, with an overall survival of 2-4 months in case of only best supportive care.. View More»
DOI:
10.4172/2167-7700.1000166